RBD’s New Biomarker Era
In REM sleep behavior disorder, a skin biopsy helps sleep specialists identify underlying pathology years before motor symptoms appear.
In REM sleep behavior disorder, a skin biopsy helps sleep specialists identify underlying pathology years before motor symptoms appear.
Most people with iRBD develop Parkinson’s disease, but a drug development company is testing whether a drug candidate could prove a viable neuroprotective strategy preventing this distressing progression.
Researchers have now identified a two-step convenient screening method to detect REM sleep behavior disorder at home.
A little-known and poorly understood sleep disorder has been garnering attention for its role in foreshadowing neurodegenerative brain diseases such as Parkinson’s disease and dementia with Lewy bodies.
Read MoreGood sleep not only helps people with neurological conditions but also may reduce the risk of developing them, new research finds.
Read MoreNewly discovered sleep biomarkers pave the way for early detection of Parkinson’s disease, Alzheimer’s disease, Lewy body dementia, and other neurodegenerative diseases. They may also one day lead to interventions.
Read MoreMount Sinai researchers say a commonly used, FDA-approved medication may be a therapeutic option for those who act out their dreams while sleeping.
Read MoreWhile the mechanism for decreased dementia risk among those with sleep-maintenance insomnia is still unknown, investigators theorize why the sleep disturbance may decrease the risk.
Read MoreThe new guideline provides updated treatment recommendations, including specific medications, for adults who act out their dreams while asleep.
Read MoreThe results open a window on the regulation of emotions during dreams and the benefits of sleep on mental health.
Read MoreREM sleep behavior disorder in patients with Parkinson’s disease did not correlate with different clinical outcomes after deep brain stimulation.
Read MorePeople with rapid eye movement (REM) sleep behavior disorder have a 50% to 80% chance of developing a serious neurodegenerative disease within a decade of diagnosis.
Read More“We can see complications in the small blood vessels of the brain in patients with RBD, although these patients don’t otherwise have any symptoms.”
Read MoreSleep scientists have discovered two novel sleep biomarkers linked to neurodegenerative disease, according to an abstract presented recently at the annual meeting of the American Academy of Neurology (AAN).
Read MoreResearchers investigated Parkinson’s disease-related sleep problems, excessive daytime sleepiness, and REM sleep behavior disorder in patients with multiple system atrophy.
Read MoreWhen the researchers blocked the input to these neurons, the mice began moving during their sleep, just like someone with RBD.
Read MoreThe researchers refer to the two types of Parkinson’s disease as body-first and brain-first. They found evidence RBD is a prodromal phenotype for the body-first type.
Read MoreScientists found that 32% of the contact sport athletes with CTE experienced sleep symptoms characteristic of REM sleep behavior disorder.
Read More